Gene Query: MDK

Dataset Description Geneva Score
Genome wide expression change in LCC2 and MCF-7 cells 145.43
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 131.05
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 129.08
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 87.42
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 83.62
RNA-seq of human fibroblasts after irradiation 83.55
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 82.71
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 77.21
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 75.43
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 73.0
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 72.62
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 60.41
RNA-seq of young and quiescent MRC-5 human fibroblasts 58.57
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 56.04
AR-independent prostate cancer is sustained through FGF signaling 55.04
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 53.4
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 52.32
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 52.08
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 50.93
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 50.81
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 50.23
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 50.12
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 49.98
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 47.92
RNA-seq analyses of human prostate cancer cells 47.53
Knockdown of ADNP in HCT116 colon cancer cells 46.65
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 46.16
Single-nucleotide-resolution mapping of HBV promoters using CAGE 46.09
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 46.08
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 46.05
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 46.05
N6-methyladenine DNA Modification in Glioblastoma 46.03
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 46.03
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 45.45
SRSF2 mutations impair hematopoiesis and alter exon recognition 45.19
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 44.75
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 44.46
TCF7L1 knockdown in pancreatic cancer 43.96
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 43.92
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 43.61
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 43.53
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 43.09
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 42.52
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 42.24
RNA-seq of human aneuploid cell lines with Trisomy 21 41.9
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 41.77
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 41.74
Neurofibroma 41.74
Gene expression analysis of immortalized human liver progenitor-like cells in culture 41.72
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 41.68
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 41.43
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 41.15
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 40.29
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 39.44
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 39.37
Cellular response to hepatitis E virus (HEV) infection 39.19
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 38.83
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 38.83
Transcriptional responses of melanoma cells to BRAF inhibition 38.76
snRNAs as regulators of alternative splicing 38.0
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 37.95
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 37.39
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 37.39
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 36.95
Interaction between mitoNEET and NAF-1 in cancer cells 36.94
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 36.91
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 36.21
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 36.06
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 35.95
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 35.77
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 35.2
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 35.14
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 34.93
High level DNA repair gene expression in human ES cells 34.93
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 34.92
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 34.92
Region-specific Innate Antiviral Responses of the Human Epididymis 34.86
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 34.43
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 34.43
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 34.41
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 34.21
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 34.2
Finding missing proteins from epigenetically manipulated human cells 34.17
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 33.74
MARS Seq data from human cortical organoids 33.52
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 33.43
mRNA expression in human DAOY cells 33.43
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 33.19
High-Throughput Kinetic Analysis of Fractional Killing 33.08
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 32.93
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 32.93
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 32.85
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 32.85
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 32.77
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 32.24
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 32.22
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 32.22
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 32.17
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 32.16
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 31.98
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 31.88
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  31.71
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 31.44
RNA-Seq from early time points in the kidney differentiation protocol 31.3
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 31.16
Molecular Mechanisms of Endothelial Hyperpermeability 31.1
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 31.01
RNA Seq of HMVEC under hypoxia 31.01
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 30.94
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 30.72
Expression profiling of etoposide-induced senescent cells 30.52
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 30.37
Nonpregnant and term pregnant human myometrial tissues 29.83
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 29.83
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 29.8
Global expression profiles in cardiac progenitor cells generated by ISX-9 29.61
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 29.61
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 29.54
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 29.47
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 29.47
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 29.44
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 29.44
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 29.34
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 28.88
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 28.83
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 28.74
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 28.7
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 28.57
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 28.53
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 28.53
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 28.46
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 28.41
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 28.41
hTERT promotes cell adhesion and migration independent of telomerase activity 28.35
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 28.29
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 27.95
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 27.71
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 27.63
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 27.59
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 27.56
METTL3 promotes translation in human cancer cells 27.32
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 27.24
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 27.2
MEIS1 regulates hematopoiesis in hPSCs 27.16
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 27.02
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 26.81
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 26.5
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 26.42
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 26.33
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 26.11
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 25.86
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 25.81
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 25.7
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 25.42
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 25.42
Control of prostate tumour growth by the long non-coding RNA GHSROS 25.33
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 25.12
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 25.1
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 24.86
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 24.85
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 24.77
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 24.76
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 24.75
CHCHD2 gene KO effect in iPSC drived motor neurons 24.68
RNAseq of T-ALL upon long non coding rna purturbation 24.67
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 24.64
DJ-1 is dispensable for human stem cell homeostasis 24.48
Differential expression of genes in AD169-infected MRC5. 24.17
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 23.98
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 23.91
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 23.46
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 23.46
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 23.4
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 23.26
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 23.11
An acquired vulnerability of drug resistant melanoma with therapeutic potential 23.11
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 23.05
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 23.05
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 23.0
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 23.0
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 22.84
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 22.84
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 22.72
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 22.51
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 22.4
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 22.4
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 22.35
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 22.33
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 22.25
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 21.95
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 21.91
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 21.87
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 21.83
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 21.81
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 21.8
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 21.76
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 21.76
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 21.61
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 21.54
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 21.53
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 21.46
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 21.44
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 21.42
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 21.4
Studying the selectivity of a small molecule Synucleozid on transcriptome 21.17
In vitro modeling of human germ cell development using pluripotent stem cells 21.17
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 21.06
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 21.01
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 20.83
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 20.71
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 20.71
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 20.71
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 20.66
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 20.64
A prostate cancer chromatin interaction map 20.62
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 20.5
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 20.5
Epigenome regulation during epidermal lineage commitment 20.41
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 20.36
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 20.26
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 20.11
NHLRC1 re-expression in cancer cells 20.09
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 20.04
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 20.02
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 20.02
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 19.82
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 19.82
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 19.72
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 19.72
Identifying the molecular mode of action of itraconazole in colorectal cancer 19.69
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 19.42
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 19.33
RNA seq comparison between scrambled and shGRP78 cells 19.31
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 19.3
SUV420H2 knockdown in PANC-1 19.27
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 19.21
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 19.15
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 19.08
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 18.98
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 18.98
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 18.85
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 18.81
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 18.74
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 18.7
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 18.65
Total RNA sequencing of WT intestinal orgaonids. 18.61
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 18.6
Identification of Atrial Fibrillation associated genes and functional non-coding variants 18.55
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 18.54
RNA expression following TMPRSS11B overexpression or depletion 18.54
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 18.51
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 18.48
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 18.39
Epigenome regulation during epidermal lineage commitment [RNA-seq] 18.37
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 18.32
PTHrP overexpression in MCF7 cells 18.31
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 18.3
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 18.24
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 18.19
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 18.01
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 17.98
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 17.98
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 17.98
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 17.97
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 17.93
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 17.92
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 17.89
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 17.85
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 17.71
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 17.65
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 17.6
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 17.48
RNA-sequencing of healthy human skeletal myocytes 17.25
NKX2.2 17.13
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 17.13
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 17.09
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 17.09
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 17.09
CHCHD10 gene KO effect in iPSC drived motor neurons 17.0
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 16.95
HNF1 regulates critical functions of the human epididymis epithelium. 16.93
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 16.93
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 16.91
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 16.88
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 16.83
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 16.83
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 16.6
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 16.51
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 16.5
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 16.49
The DPYSL2 gene connects mTOR and schizophrenia 16.49
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 16.4
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 16.38
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 16.38
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 16.37
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 16.34
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 16.27
Gene profiling of human adult and pediatric liver cancer cells 16.23
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 16.17
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 16.15
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 16.06
HEK293 TFAM Knockout Expression Study 15.93
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 15.85
Targeting EZH2 in MYCN-amplified Neuroblastoma 15.85
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 15.83
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 15.72
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 15.72
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 15.66
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 15.41
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 15.39
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 15.38
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 15.35
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 15.15
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 15.12
CDK4/6 inhibitor resistance in prostate cancer 15.02
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 14.96
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 14.96
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 14.65
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 14.61
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 14.6
Patient-derived luminal breast cancer xenografts with progestins 14.6
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 14.56
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 14.56
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 14.49
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 14.47
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 14.26
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 14.02
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 13.91
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 13.77
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 13.7
Global analyses of the effect of different cellular contexts on microRNA targeting 13.62
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 13.62
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 13.52
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 13.1
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 13.1
Gene expression changes in human melanoma cell lines compared to primary melanocytes 13.04
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 13.02
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 12.91
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 12.83
RNA-seq of MCF10A cells and CAF 12.73
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 12.66
Gene expression profiling of KSHV-infected periodontal ligament cells 12.65
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 12.62
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 12.51
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 12.46
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 12.33
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 12.29
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 12.04
Single cell transcriptome of peritoneal cells 11.87
RNA-seq analysis of uveal melanoma cells treated with FR900359 11.81
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 11.55
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 11.42
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 11.35
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 11.22
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 10.91
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 10.83
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 10.8
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 10.75
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 10.64
SLAM-seq for K562 endogenous mRNA decay 10.54
Expression charcaterization of an internal protocol developed to differentiate RPE cells 10.37
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 10.27
RNA-Seq of Breast and Ovarian Cancer Cell Lines 10.02
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 9.91
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 9.84
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 9.83
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 9.68
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 9.68
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 9.53
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 9.53
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 9.53
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 9.47
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 9.44
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 9.44
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 9.36
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 9.31
ARID1A and ARID1B loss in HCT116 and TOV21G cells 9.24
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 9.16
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 9.07
Gene expression patterns define the hepatocyte-like cells derived by different strategies 9.07
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 9.06
9.06
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 9.03
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 8.74
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 8.68
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 8.6
Activity-dependent transcriptional changes in human neurons 8.49
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 8.42
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 8.32
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 8.22
RNA-seq analysis of gene expression patterns during hESC neural differentiation 8.18
hESC neural differentiation 8.18
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 8.17
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 8.03
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 7.93
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 7.41
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 7.21
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 7.04
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 7.03
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 7.03
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  6.98
Energy Metabolism during Anchorage-Independence 6.94
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 6.91
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 6.91
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 6.85
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 6.81
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 6.81
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 6.75
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 6.63
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 6.59
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 6.45
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 6.45
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 5.91
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 5.89
Identification of long noncoding RNAs regulated by p53 5.6
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 5.35
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 5.35
Gene expression profiling in metabolically heterogeneous human lung tumors 5.29
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 5.24
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 5.17
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 5.17
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 5.06
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 4.93
RNA-seq of cancer cell lines treated with T-025 4.9
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 4.55
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 4.5
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 4.39
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 4.31
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 4.31
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 4.25
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 4.22
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 4.11
Metabolism as an early predictor of DPSCs aging 4.04
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 3.63
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 3.5
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 3.5
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 3.44
Iron response of HepG2 cells 3.39
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 3.34
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 3.34
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 3.3
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 3.3
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 3.25
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 2.88
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 2.86
Hepatocyte maturation 2.82
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 2.8
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 2.7
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 2.7
Hepatic transcriptome of pediatric hepatoblastoma. 2.66
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 2.65
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 2.53
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 2.49
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 2.48
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 2.4
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.4
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.38
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.38
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.26
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.26
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 2.19
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 2.14
Direct Isolation and Characterization of Human Nephron Progenitors. 2.11
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 2.05
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 2.05
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 2.05
Identification of a LIF-responsive replication-competent human β cell 1.99
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 1.98
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.7
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.7
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 1.66
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 1.63
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 1.44
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.43
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.35
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.12
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.0
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.92
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.84
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.8
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 0.77
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.75
Comparative Analysis of Cas9 Activators Across Multiple Species 0.68
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.65
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.62
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 0.6
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.6
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.58
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.54
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.47
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 0.45
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.43
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.38
Gene expression of thyroid cancer cell lines 0.27
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.23
Gene expression analysis of breast cancer cell-lines 0.23
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.19
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.17
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 0.04
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation